fluoxetine has been researched along with Uterine Cervical Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hariharan, R; Krishnan, A; Nair, SA; Pillai, MR | 1 |
1 other study(ies) available for fluoxetine and Uterine Cervical Neoplasms
Article | Year |
---|---|
Fluoxetine mediates G0/G1 arrest by inducing functional inhibition of cyclin dependent kinase subunit (CKS)1.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carrier Proteins; CDC2-CDC28 Kinases; Cell Line, Tumor; Cell Survival; Cyclin A; Cyclin E; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclophosphamide; Female; Fibroblasts; Fluoxetine; G1 Phase; Humans; Resting Phase, Cell Cycle; RNA, Messenger; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2008 |